JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 22 No. 8 703-709
© 1981 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Kieviet, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Kieviet, W.

Technetium Radiopharmaceuticals: Chemical Characterization and Tissue Distribution of Tc-Glucoheptonate Using Tc-99m and Carrier Tc-99

Wim de Kieviet

Rotterdamsch Radio-Therapeutisch Instituut, Rotterdam, The Netherlands

Correspondence: For reprints contact: Wim de Kieviet, PhD, Dept. of Nuclear Medicine, Rotterdamsch Radio-Therapeutisch Instituut, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.

ABSTRACT

The chemical structure of the kidney- and brain-imaging agent Tc-99m glucoheptonate has been established using the Tc-99 isotope. In a comparative study between Tc-99 and Tc-99m glucoheptonates, chromatographic, electrophoretic, and tissue distribution studies showed identical compounds in 0.9% NaCl. Optimal conditions for the formation of the Tc-99 glucoheptonate complex were investigated by uv and visible spectroscopy. The oxidation state of Tc-99 in the compound is V, measured by Sn2+ titration. The complex contains a Tc = O core and two glucoheptonate ligands (oxobis(glucoheptonato)technetate(V) anion (net charge: –1) in aqueous solution). NMR studies demonstrated two five-membered glucoheptonate rings, bidentate bound to Tc by the oxygens of the end carboxyl group and the adjacent hydroxyl group. The compound is stabilized by interaction between Tc-99 and one of the hydroxyloxygens of glucoheptonate at the vacant coordination site trans to the Tc = O core. Experiments with the reducing agent NaBH4 demonstrated the absence of Sn (II or IV) in the complex and a biological behavior independent of the reducing agent used.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1981 by the Society of Nuclear Medicine.